Trileptal (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Trileptal drug offered from Novartis Pharmaceuticals Corporation. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | oxcarbazepine |
| SUBSTANCE NAME: | OXCARBAZEPINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2000-01-30 |
| END MARKETING DATE: | 0000-00-00 |
Trileptal HUMAN PRESCRIPTION DRUG Details:
| Item Description | Trileptal from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/1) |
| START MARKETING DATE: | 2000-01-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0337_99a2ba76-61e7-4559-b029-c2158783eba8 |
| PRODUCT NDC: | 0078-0337 |
| APPLICATION NUMBER: | NDA021014 |
Other OXCARBAZEPINE Pharmaceutical Manufacturers / Labelers:
